Four Years' Experience of Long-Term Hemofiltration in a Swedish Center

REFERENCES

• Baldamus CA, Knobloch M, Schoeppe W, Koch KM. Hemodialysis/hemofiltration: A report of a controlled cross-over study. Int J Artif Organs 1980; 3: 211–214.
   PubMed Web of Science ®Google Scholar
• Bardin T, Kuntz D, Zingraff J, Voisin M-C, Zelmar A, Lansaman J. Synovial amyloidosis in patients undergoing long-term hemodialysis. Arthritis Rheum 1985; 28: 1052–1058.
   PubMed Web of Science ®Google Scholar
• Bergström J, Asaba H, Fürst P, Qulés R. Dialysis, ultrafiltration and blood pressure. Proc Eur Dial Transplant Assoc 1976; 13: 293–305.
   Google Scholar
• Bergström J, Wehle B. No change in corrected β2-microglobulin concentration after cuprophane haemodialysis. Lancet 1987; i: 628–629.
   Google Scholar
• Brown EA, Arnold IR, Gower PE. Dialysis arthropathy: Complication of long-term treatment with haemodialysis. Br Med J 1986; 292: 163–166.
   PubMed Web of Science ®Google Scholar
• Canaud B, Araujo A, Sany C, Farrell PC, Garred LJ, Shaldon S, Mion C. A urea kinetic model for hemofiltration. Life Supp 1985; 3: 15–25.
   PubMedGoogle Scholar
• Chenoweth DE, Cheung AK, Henderson LW. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes. Kidney Int 1983; 24: 764–769.
   PubMed Web of Science ®Google Scholar
• Clyne N, Lins LE, Pehrsson SK. Heart disease in uremia. Blood Purif 1983; 1: 102 (abstract).
   Google Scholar
• De Fremont JF, Faguer P, Man NK, Morinière P, Fournier A. Evaluation of hemofiltration (HF) with ten liters of substitution fluid (SF). Blood Purif 1983; 1: 44.
   Google Scholar
• De Fremont JF, Moriniére P, Pruna A, Gheerbrandt JD, Kassouf J, Roussel A, Galy C, Fournier A. Long-term evaluation of hemofiltration at home. Contr Nephrol 1982; 32: 119–127.
   PubMed Web of Science ®Google Scholar
• Degoulet P, Réach I, Di Giulio S, Devnès C, Rouby JJ, Aimé F, Vonlanthen M. Epidemiology of dialysis-induced hypotension. Proc Eur Dial Transplant Assoc 1981; 18: 133–138.
   PubMedGoogle Scholar
• Fenves AZ, Emmett M, White MG, Greenway G, Michaels DB. Carpal tunnel syndrome with cystic bone lesions secondary to amyloidosis in chronic hemodialysis patients. Am J Kidney Dis 1986; 7: 130–134.
   PubMed Web of Science ®Google Scholar
• Gejyo F, Homma N, Suzuki Y, Arakawa M. Serum levels of β2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis. N Engl J Med 1986; 314: 585–586.
   PubMed Web of Science ®Google Scholar
• Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunitomo T, Kataoka H, Suzuki M, Hirasawa Y, Shirahama T, Cohen AS, Schmid K. A new form of amyloid protein associated with chronic haemodialysis was identified as β2-microglobulin. Biochem Biophys Res Commun 1985; 129: 701–706.
   PubMed Web of Science ®Google Scholar
• Graefe U, Milutinovich J, Follette WC, Vizzo JE, Babb AL, Scribner BH. Less dialysis-induced morbidity and vascular instability with bicarbonate in dialysate. Ann Intern Med 1978; 88: 332–336.
   PubMed Web of Science ®Google Scholar
• Hehrmann R, Nordmeyer H, Mohr M, Hesch R-D. Human parathyroid hormone: antibody characterization. J Immunoassay 1980; 1: 151–174.
   Google Scholar
• Henderson LW, Sanfelippo ML, Stone RA. Hemofiltration for long-term maintenance of patients with endstage renal disease: Impact on hypertension. Adv Nephrol 1980; 9: 21–32.
   PubMedGoogle Scholar
• Horensten ML, Boner G, Rosenfeld JB. The shrinking man. A manifestation of severe renal osteodystrophy. JAMA 1980; 244: 267–268.
   PubMed Web of Science ®Google Scholar
• Jörstad S, Smeby LC, Balstad T, Widerôe T-E. Removal, generation and adsorption of beta-2-microglobulin during hemofiltration with five different membranes. Blood Purif 1988; 6: 96–105.
   PubMed Web of Science ®Google Scholar
• Kishimoto T, Yamagami S, Tanaka H, Ohyama T, Yamamoto T, Yamakawa M, Nishino M, Yoshimoto S, Maekawa M. Superiority of hemofiltration to hemodialysis for treatment of chronic renal failure: Comparative studies between hemofiltration and hemodialysis on dialysis disequilibrium syndrome. Artif Organs 1980; 4: 86–93.
   PubMedGoogle Scholar
• Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription on patient morbidity. N Engl J Med 1981; 305: 1176–1181.
   PubMed Web of Science ®Google Scholar
• Lundin AP, Adler AJ, Feinroth MV, Berlyne GM, Friedman EA. Maintenance hemodialysis. Survival beyond the first decade. JAMA 1980; 244: 38–40.
   PubMed Web of Science ®Google Scholar
• Massry SG. The toxic effects of parathyroid hormone in uremia. Semin Nephrol 1983; 4: 306–328.
   Google Scholar
• Nielsen VK. The peripheral nerve function in chronic renal failure. V. Sensory and motor conduction velocity. Acta Med Scand 1973; 194: 445–454.
   PubMedGoogle Scholar
• Port FK, Johnson WJ, Klass DW. Prevention of dialysis dysequilibrium syndrome by use of high sodium concentration in the dialysate. Kidney Int 1973; 3: 327–333.
   PubMed Web of Science ®Google Scholar
• Potasman I, Better OS. The role of secondary hyperparathyroidism in the anemia of chronic renal failure. Nephron 1983; 33: 229–231.
   PubMed Web of Science ®Google Scholar
• Quellhorst E, Rieger J, Doht B, Beckmann H, Jacob I, Kraft B, Mietzsch G, Scheler F. Treatment of chronic uraemia by an ultrafiltration kidney—first clinical experience. Proc Eur Dial Transplant Assoc 1976; 13: 314–321.
   Google Scholar
• Quellhorst E, Schuenemann B, Hildebrand U. Morbidity and mortality in long-term hemofiltration. ASAIO J 1983; 6: 185–191.
   Google Scholar
• Quellhorst E, Schuenemann B, Hildebrand U, Neumann W. Hypertension and hemofiltration. Contrib Nephrol 1982; 32; 46–55.
   PubMed Web of Science ®Google Scholar
• Shaldon S, Deschodt G, Beau MC, Claret G, Mion H, Mion C. Vascular stability during high flux haemofiltration. Proc Eur Dial Transplant Assoc 1979; 16: 695–697.
   PubMedGoogle Scholar
• Wehle B, Asaba H, Castenfors J, Fürst P, Gunnarson B, Shaldon S, Bergström J. Hemodynamic changes during sequential ultrafiltration and dialysis. Kidney Int 1979; 15: 411–418.
   PubMed Web of Science ®Google Scholar
• Zappacosta AR, Caro J, Erslev A. Normalization of hematocrit in patients with end-stage renal disease on continuous ambulatory peritoneal dialysis. The role of erythropoietin. Am J Med 1982; 72: 53–57.
   PubMed Web of Science ®Google Scholar